TI
RAPT

Telemetry Investments’s RAPT Therapeutics RAPT Stock Holding History

Telemetry Investments’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$238K Buy
+1,500
New +$240K 0.38% 64

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Telemetry Investments's RAPT Position: Q4 2022 in Review

Telemetry Investments opened a new position in RAPT Therapeutics (RAPT) in Q4 2022: 1,500 shares worth $238K. The stake represents 0.38% of the portfolio and ranks #64 among its holdings.

95 funds tracked by Wall St. Rank hold RAPT as of Q4 2022.

  • Telemetry Investments held 1,500 shares of RAPT Therapeutics worth $238K as of Q4 2022.
  • RAPT Therapeutics was a new Telemetry Investments position in Q4 2022.
  • RAPT Therapeutics made up 0.38% of Telemetry Investments's portfolio in Q4 2022, its #64 holding.
  • 95 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.